
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Supplements and Featured Publications
over 30 years ago
Introductionover 30 years ago
Switch Therapy: Development, Implementation, and Economicsover 30 years ago
CPE Questions





